| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $5.34 | $4.86 | $5.09 | $5.32 | $3.86 | $1.00 | $1.10 | $1.02 |
| EPS (Diluted) | $5.31 | $4.83 | $5.07 | $5.31 | $3.86 | $1.00 | $1.09 | $1.02 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.3B | $15.6B | $14.5B | $13.1B | $13.5B | $9.8B | $7.3B | $5.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $2.0B | $0.5B | $0.2B | $0.2B |
| Total Liabilities | $15.3B | $13.8B | $12.8B | $11.5B | $12.0B | $8.7B | $6.5B | $5.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.0B | $1.8B | $1.7B | $1.5B | $1.5B | $1.1B | $0.9B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-1.1B | $-0.8B | $-1.3B | $-1.4B | $-0.0B | $-0.7B | $-0.4B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.8B | $0.9B | $1.2B | $-0.6B | $1.3B | $0.9B | $0.3B | $0.3B |